Debate - PRO: TEVAR in the subacute phase is the treatment of choice for patients with uncomplicated type B aortic dissection

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Aug 8 2023

Publication series

NameArticles, Abstracts, and Reports

Cite this